Sabby Management’s ImmunoCellular Therapeutics, Ltd. IMUC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q2 | – | Sell |
-139,912
| Closed | -$445K | – | 355 |
|
|
2017
Q1 | $445K | Sell |
139,912
-20,217
| -13% | -$52.8K | 0.31% | 185 |
|
|
2016
Q4 | $328K | Sell |
160,129
-2
| -0% | -$6 | 0.1% | 224 |
|
|
2016
Q3 | $756K | Buy |
160,131
+48,828
| +44% | +$314K | 0.27% | 204 |
|
|
2016
Q2 | $1.02M | Buy |
111,303
+1,019
| +0.9% | +$10.5K | 0.35% | 157 |
|
|
2016
Q1 | $1.28M | Sell |
110,284
-814
| -0.7% | -$9.16K | 0.26% | 139 |
|
|
2015
Q4 | $1.58M | Buy |
111,098
+6,867
| +7% | +$113K | 0.53% | 148 |
|
|
2015
Q3 | $1.75M | Sell |
104,231
-42,564
| -29% | -$775K | 0.35% | 173 |
|
|
2015
Q2 | $2.77M | Sell |
146,795
-431
| -0.3% | -$8.29K | 0.7% | 136 |
|
|
2015
Q1 | $2.86M | Buy |
+147,226
| New | +$3.7M | 0.8% | 115 |
|
|
2014
Q4 | – | Hold |
0
| – | – | – | 374 |
|
|
2014
Q3 | – | Hold |
0
| – | – | – | 388 |
|
|
2014
Q2 | – | Hold |
0
| – | – | – | 365 |
|
|
2014
Q1 | – | Sell |
-625
| Closed | -$30.6K | – | 371 |
|
|
2013
Q4 | $23K | Buy |
+625
| New | +$59.2K | 0.01% | 215 |
|
|
2013
Q3 | – | Hold |
0
| – | – | – | 328 |
|
Other funds holding IMUC
WS
VKH
